Trial Profile
Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients: a Retrospective Analysis of a Portuguese Cohort Treated Within the Expanded Access Program.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Antiretrovirals (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections; HIV-2 infections
- Focus Pharmacodynamics; Therapeutic Use
- 08 Sep 2010 New trial record